Cory berkland.

Cory Berkland The University of Kansas Verified email at ku.edu. Paulette Spencer Ackers Distinguished Professor, ... M Lazebnik, M Singh, P Glatt, LA Friis, CJ Berkland, MS Detamore. Journal of tissue engineering and regenerative medicine 5 (8), e179-e187, 2011. 80: 2011: Fatigue performance of composite analogue femur constructs under high ...6 records for Cory Berkland. Find Cory Berkland's phone number, address, and email on Spokeo, the leading online directory for contact information.ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. HHS Author Manuscripts. Nanoparticles of PLG have been widely studied for their use in drug delivery. 8600 Rockville Pike Bethesda, MD 20894. HHS Vulnerability Disclosure.Berkland C, King M, Cox A, Kim K, Pack DW. Precise control of PLG microsphere size provides enhanced control of drug release rate . Journal of Controlled Release . 2002 Jul 18;82(1):137-147. doi: 10.1016/S0168-3659(02)00136-0

C. Berkland, K. Kim, and D.W. Pack (2004) Controlling double-walled microcapsule shell thickness offers modulated piroxicam release Journal of Biomedical Materials Research 70A(4):576-584 C. Berkland, K. Kim, and D.W. Pack (2004) Uniform double-walled polymer microspheres of controllable shell thickness Journal of Controlled Release, 96(1):101-111 Great news for Engineering Distinguished Professor Cory Berkland... Quote. University of Kansas · @UnivOfKansas. ·. Mar 30, 2017. A KU pharmaceutical ...Cory Berkland Professor Biomedical Engineering [email protected] Google Scholar Education PhD, University of Illinois, 2003 MS, University of Illinois, 2001 BS, Iowa State University, 1998 Research areas Advanced Materials Biomedical, Bio-inspired, and Bio-derived Materials Cell & Molecular Bioengineering Regenerative Engineering in Medicine

Cory Berkland, CEO [email protected]. Release Summary. Phase Ia/b will assess the safety of BBI-001 and test the ability of BBI-001 to prevent iron uptake from food. Contacts.

Wei Bin Fang 1, Min Yao 1, Gage Brummer 1, Diana Acevedo 1, Nabil Alhakamy 2, Cory Berkland 2, Nikki Cheng 1. 1 Department of Pathology and Laboratory, University of Kansas Medical Center, Kansas City, KS 66160, USA. 2 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66045, USA. Correspondence to: Nikki Cheng, email ...Cory Berkland. 2004, Biomaterials. Improved control of surface micro-and nano-structure may lead to enhanced performance of degradable biomedical devices such as surgical dressings, vascular grafts, tissue engineering scaffolds, sutures, and structures for guided tissue regeneration. An electrohydrodynamic method called flow-limited field ...Cory Berkland Magnetic nanoparticles that display high saturation magnetization and high magnetic susceptibility with a size less than 200 nm are of great interest for medical applications.Cory Berkland, Ph.D.-Solon E. Summerfield Distinguished Professor-Chemical and Petroleum Engineering-Pharmaceutical Chemistry; View full profile . Jonathan Brumberg, Ph.D.-Associate Professor, Speech-Language-Hearing: Sciences & Disorders-Courtesy Associate Professor, Electrical Engineering & Computer Science;Amir Fakhari 1 , Quang Phan, Santosh V Thakkar, C Russell Middaugh, Cory Berkland. Affiliation 1 Bioengineering Graduate Program, University of Kansas, Lawrence, Kansas 66045, USA. PMID: 23514620 DOI: 10.1021/la304575x Abstract Hyaluronic acid (HA) is a glycosaminoglycan with diverse biomedical applications including viscosupplementation of ...

Cory Berkland. Cory Berkland. Solon E. Summerfield Distinguished Professor. Department of Pharmaceutical Chemistry. Contact Info. [email protected].

In recent history, through the merger of engineering and biological sciences, biotechnology has pressed toward improving methods for regenerating tissues, developing biosensors, and effectively delivering therapeutic agents.

Inventors: Cory Berkland, Milind Singh Extended-release drug delivery compositions. Patent number: 10238663 Abstract: An extended-release drug delivery composition and method of administering the same is provided. The composition comprises microspheres loaded with a biologically-active agent and suspended in a soluble polymer capable of forming ...Search 4 grants from Maria Flynn Search 22 grants from Cory Berkland Search grants from Ronald Beyerinck Search grants from David Newbold Search grants from Orbis Biosciences, Inc.Cory Berkland: Resources, Writing - review & editing. Michael J. Hageman: Writing - review & editing, Project administration, Supervision, Resources. Declaration of Competing Interest. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in ...Director, Partner Marketing at Exabeam. Erika Berkland is a Director, Partner Marketing at Exabeam based in Foster City, California. Previously, Erika was a Senior Manager, Channel Marke ting at Gigamon and also held positions at LogRhythm, SendGrid, Women's Wilderness, Coleman, IBM, Gartner, Gartner. Read MoreSingkome Tima 1 , Siriporn Okonogi 2 , Chadarat Ampasavate 2 , Chad Pickens 3 , Cory Berkland 4 , Songyot Anuchapreeda 5 Affiliations 1 Nanoscience and Nanotechnology Program, Graduate School, Chiang Mai University, Chiang Mai 50200, Thailand.The toll-like receptor 7 and 8 (TLR7/8) agonist Resiquimod (R848) has been recognized as a promising immunostimulator for the treatment of cutaneous cancers in multiple clinical trials. However, systemic administration of R848 often results in strong immune-related toxicities while having limited th …

Aillon Kristin L, El-Gendy Nashwa, Dennis Connor, Norenberg Jeffrey P, McDonald Jacob, Berkland Cory. Iodinated NanoClusters as an Inhaled Computed Tomography Contrast Agent for Lung Visualization. Molecular Pharmaceutics. 2010; 7 (4):1274–1282. [PMC free article] [Google Scholar]Jan 25, 2022 · Cory Berkland, CEO [email protected] Release Summary Bond’s clinical lead, BBI-001, is designed to rapidly and selectively bind dietary iron to reduce iron absorption in patients with iron overload. Zahra Mohammadi, Amanda Cole and Cory J. Berkland . In Situ Synthesis of Iron Oxide within Polyvinylamine Nanoparticle Reactors. The Journal of Physical Chemistry C 2009, 113 (18) , 7652-7658. DOI: 10.1021/jp901036b. Zahra Mohammadi, Amanda Cole and Cory J. Berkland . In Situ Synthesis of Iron Oxide within Polyvinylamine Nanoparticle Reactors. ...C. Berkland et al. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J. Controlled Release (2001) ... Cory Berkland. Functions of the plasminogen receptor Plg‐R KT. Journal of Thrombosis and Haemostasis, Volume 18, Issue 10, 2020, pp. 2468-2481.C. Berkland et al. Precise control of PLG microsphere size provides enhanced control of drug release rate. J. Control. Release (2002) ... Cory Berkland. Protein Encapsulation in and Release from Monodisperse Double-Wall Polymer Microspheres. Journal of Pharmaceutical Sciences, Volume 102, Issue 5, 2013, pp. 1601-1609 ...The long-term objective of this application is to deliver a unique biomaterial that can easily be molded into place by a surgeon, and will resorb as it induces rapid tissue regeneration. Toward this o...

Berkland C, Kim K, Pack DW. PLG microsphere size controls drug release rate through several competing factors . Pharmaceutical Research . 2003 Jul 1;20(7):1055-1062. doi: 10.1023/A:1024466407849

Cory Berkland Mario Rivera Kate ESHELMAN Jian QIAN Nashwa EL-GENDY Original Assignee The University Of Kansas Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2014-10-10 Filing date 2015-10-08 Publication ...Cory Berkland Autoimmune diseases are characterized by aberrant immune responses toward self-antigens. Current treatments lack specificity, promoting adverse effects by broadly suppressing the...Integrated Science Building (ISB) 1567 Irving Hill Road, Room 1140 Lawrence, KS 66045 [email protected] 785-864-4670Cory Berkland [email protected] Department of Chemical and Petroleum Engineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047.Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...Fah Chueahongthong; Singkome Tima; Sawitree Chiampanichayakul; Cory Berkland; Songyot Anuchapreeda: 1-Jan-2022 ...Collaborators: Michael Detamore, Jenn-Tai Liang, Paul Willhite, Teruna Siahaan, others! Postdocs: Jian Qian, Sheng-Xue Xie, Huili Guan, Nashwa El-Gendy, Ying-Ying Lin,Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...Chad Groer 1 , Ti Zhang 1 , Ruolin Lu 2 , Shuang Cai 1 , Derek Mull 1 2 , Aric Huang 2 , Melanie Forrest 1 , Cory Berkland 2 3 , Daniel Aires 1 4 , Marcus Laird Forrest 1 2 Affiliations 1 HylaPharm LLC, 2029 Becker Dr, Lawrence, Kansas 66047, United States.

Cory Berkland, Ph.D.-Solon E. Summerfield Distinguished Professor-Chemical and Petroleum Engineering-Pharmaceutical Chemistry; View full profile . Jonathan Brumberg, Ph.D.-Associate Professor, Speech-Language-Hearing: Sciences & Disorders-Courtesy Associate Professor, Electrical Engineering & Computer Science;

Cory Berkland. The Berkland Lab investigates pharmaceuticals and biomaterials. They aim to understand the transport of pharmaceuticals as a function of physical and chemical properties. Biomaterials are also investigated for applications in regenerative medicine. Faculty Profile. Berkland Research Lab.

The main apparatus (Fig. 1A), which provides fabrication of monodisperse microparticles, is based on passing a solution containing the sphere material, and any drug to be encapsulated, through a small nozzle or other orifice (20 μm to a few millimeters in diameter) to form a smooth, cylindrical jet.To controllably break the jet into droplets, the nozzle is vibrated by a piezoelectric ...Cory Berkland Songyot Anuchapreeda: Keywords: Agricultural and Biological Sciences;Biochemistry, Genetics and Molecular Biology;Chemistry: Issue Date: 1-Jan-2021: Abstract: The magnolia plant has been used in traditional medicine since ancient times. This study was designed to investigate the effects of active compounds from Thai Champi ...1. Introduction. Injectable scaffolds have received attention due to their potential for avoiding the invasive surgery typically required for tissue implantation. 1 From a clinical perspective, the use of injectable materials is an attractive alternative to surgery as it reduces the risk of infection, scar formation, patient discomfort and the cost of treatment. 2 Injectable scaffolds may be ...Khia Preston Director Of Operations at The UPS Store - #3263, 2473, 3354, 3723, 1152, 3443, 0754Abstract. Lung surfactant is crucial for optimal pulmonary function throughout life. An absence or deficiency of surfactant can affect the surfactant pool leading to respiratory distress. Even if the coupling between surfactant dysfunction and the underlying disease is not always well understood, using exogenous surfactants as replacement is ...Europe PMC is an archive of life sciences journal literature.Author: Susan MacNally Created Date: 08/20/2021 11:09:00 Title: Conflict management plan for Cory Berkland (L0013204-5).DOC Subject: L0013204 / 5 Last modified byCory Berkland, CEO [email protected]. Release Summary. Phase Ia/b will assess the safety of BBI-001 and test the ability of BBI-001 to prevent iron uptake from food. Contacts.

864-1455, Fax: (785) 864-1454, [email protected]. ‡Authors contributed equally to this work Supporting Information Figure S1. HSQC NMR data for DEX-N3. Figure S2. Levels of IFN-γ at peak of disease. Figure S3. Levels of IL-6 at peak of disease. Figure S4. Levels of IL-15 at peak of disease. Figure S5. Levels of IL-17A at peak of disease ...So Cory Berkland and colleagues set out to find new kinds of pharmaceuticals to fight weight gain. Targeting the body's process of absorbing fat, the researchers designed a class of polymers that ...Intercellular cell-adhesion molecule-1 (ICAM-1) is up-regulated on the vascular endothelium in response to pro-inflammatory cytokines produced in the synovial cavity of patients with Rheumatoid Arthritis.liquid droplets (Berkland et al. 2001). A schematic diagram of the PPF nozzle is illustrated in Figure 1. The PLGA/ analyte solution is forced via a syringe pump (New Era Pump Systems, Wantagh, NY) through a 22-gauge hypo-dermic needle at flow rates from 1-10 mL h 1. An annular immiscible stream of water containing a mass concentra-Instagram:https://instagram. ph.d in physical educationgoldwater v carterkusports.com appha 335 Noncovalently associated cell-penetrating peptides for gene delivery applications. 2013 Jun;4 (6):741-57. doi: 10.4155/tde.13.44. Nabil A Alhakamy Adane S Nigatu Cory J Berkland Joshua D Ramsey. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA. 23738670. bennie dillon original loftsh. w. bush Nabil A Alhakamy 1 , David T Curiel 2 , Cory J Berkland 3 Affiliations 1 Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ... University of Kansas, Lawrence, KS 66047, USA. Electronic address: [email protected]. PMID: 33781953 DOI: 10.1016/j.drudis.2021.03.021 AbstractCory Berkland Assistant Professor Department of Pharmaceutical Chemistry Assistant Professor Department of Chemical and Petroleum Engineering The University of Kansas. 2 Acknowledgements Postdocs: David Shi, Nancy Zhang, Laura Peek, Min Huang Graduate Students: brqrary Lianjun Shi 1 , Cory Berkland. Affiliation 1 Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KS 66047. PMID: 18797513 PMCID: PMC2537468 DOI: 10.1021/ma070443o Abstract Hollow nanoparticles represent an emerging area of development for the encapsulation of active ingredients. ...LAWRENCE — Cory Berkland might not be the first person you’d guess would help to create what has become a multimillion-dollar company. The distinguished professor, appointed in the departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering at the University of Kansas, grew up on a pig farm in Iowa, studied chemical engineering at the undergraduate and graduate levels and ...864-1455, Fax: (785) 864-1454, [email protected]. ‡Authors contributed equally to this work Supporting Information Figure S1. HSQC NMR data for DEX-N3. Figure S2. Levels of IFN-γ at peak of disease. Figure S3. Levels of IL-6 at peak of disease. Figure S4. Levels of IL-15 at peak of disease. Figure S5. Levels of IL-17A at peak of disease ...